Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 22/02/2008

    Michael Kuner joins Nycomed Executive Committee

    Nycomeds Board of Directors has appointed Michael Kuner Executive Vice President Legal. He joins the companys Executive Committee with immediate effect.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/michael-kuner-joins-nycomed-executive-committee
  • Article - 21/02/2008 Dr. Gerrit Begemann is is standing in front of an aquarium.

    The females choose their mates

    The team of researchers led by evolutionary biologist Dr. Gerrit Begemann at Constance University is using swordtails to investigate the development of traits that evolved by sexual selection. Their major focus is the molecular mechanism of growth control in the caudal fin. Or put more simply why do these fish have swords?

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-females-choose-their-mates
  • Article - 21/02/2008

    The inversion of the dorsoventral axis in the separation of Bilataria

    The basic classification of bilateral animals is based on the comparison of their embryonic development and was confirmed in modern molecular phylogeny by the analysis of the relationship of the genes involved. Conserved groups of genes are responsible for the formation of the body axes.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-inversion-of-the-dorsoventral-axis-in-the-separation-of-bilataria
  • Press release - 20/02/2008

    ZRM and Naturin develop innovative biomembranes

    The Centre for Regenerative Biology and Medicine ZRM in Tübingen has joined forces with Naturin GmbH based in Weinheim. The partners plan to develop new carrier materials on the basis of collagen which improve cell cultures and medical implants.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/zrm-and-naturin-develop-innovative-biomembranes
  • Article - 20/02/2008 Scanning electron microscope image of Caenorhabditis elegans and Pristionchus pacificus.

    Threadworms throughout time

    Threadworms are versatile research objects and are excellent models for investigating fundamental evolutionary principles. Researchers at the Max Planck Institute for Developmental Biology use the Caenorhabditis and Pristionchus threadworm genera to study the molecular mechanisms of biodiversity.

    https://www.gesundheitsindustrie-bw.de/en/article/news/threadworms-throughout-time
  • Article - 18/02/2008

    Medical technology system leadership

    The Fraunhofer Institute for Industrial Engineering IAO in Stuttgart is investigating the potential for system leaderships in computer-assisted medical technology from a holistic perspective. The project is part of the SysteMedic project.

    https://www.gesundheitsindustrie-bw.de/en/article/news/medical-technology-system-leadership
  • Article - 18/02/2008 Cell culture

    Baden-Württemberg to fund MediCyte research

    MediCyte GmbH based in the Heidelberg Technology Park is among the winners of the Baden-Württemberg Ministry of Science Research and the Arts biotechnology funding programme. The company will establish innovative cell culture systems.

    https://www.gesundheitsindustrie-bw.de/en/article/news/baden-wuerttemberg-to-fund-medicyte-research
  • Press release - 18/02/2008

    Health regions of the future

    The German Federal Research Minister Annette Schavan launched the Health Regions of the Future contest.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/health-regions-of-the-future
  • Press release - 17/02/2008

    Baden-Württemberg number one in EU

    With the investment of 4.2 per cent of its gross domestic product in research and development Baden-Württemberg leads other German states and European countries in this sector. The 27 European states spent an average of only 1.8 per cent.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/baden-wuerttemberg-number-one-in-eu
  • Article - 17/02/2008

    Nycomed extends geographic reach

    Nycomed is about to establish its own marketing and sales organisation in Venezuela. With this the company will operate from an own subsidiary in all four leading Latin American pharmaceutical markets Mexico Brazil Venezuela and Argentina.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nycomed-extends-geographic-reach
  • Article - 16/02/2008

    Haemochromatosis is a disease of the liver

    Haemochromatosis is not as has been previously assumed a disease of the small intestine but a disease of the liver. Scientists from Heidelberg have shown in the animal model that the disease is caused by a mutated gene influencing hepcidin production.

    https://www.gesundheitsindustrie-bw.de/en/article/news/haemochromatosis-is-a-disease-of-the-liver
  • Article - 16/02/2008

    New test for the early diagnosis of cervical cancer

    mtm laboratories has launched the Cervatec assay for the early diagnosis of cervical cancer. The Cervatec assay will initially be commercialized as an adjunct to the Pap test for the screening of women aged 35 and younger.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-test-for-the-early-diagnosis-of-cervical-cancer
  • Article - 15/02/2008

    DNA, an eternal mystery

    Although the biomolecule DNS has provided many explanations and hopeful projections opinions are divided over the question of DNA being the carrier of genetic information. There is a huge need for clarification. Biologists clinicians psychologists lawyers and bioethicists discussed in Tübingen.

    https://www.gesundheitsindustrie-bw.de/en/article/news/dna-an-eternal-mystery
  • Article - 15/02/2008

    "MedTech-Compass" of BVMed released

    The German Medical Technology Association BVMed is hoping that the new information campaign MedTech-Compass will promote transparent and effective cooperation between the industry medical institutions and physicians.

    https://www.gesundheitsindustrie-bw.de/en/article/news/medtech-compass-of-bvmed-released
  • Press release - 14/02/2008

    Space sickness - learning from fish

    Gravitation biologist Dr. Ralf Anken of the University of Hohenheim talks about his research with fish in an interview with Sandra Leppin from Hohenheim University. Anken At zero gravity the impressions received by the eyes and the organs of equilibrium do not coincide.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/space-sickness-learning-from-fish
  • Press release - 14/02/2008

    University strengthens applied research

    In its applied science and technology transfer activities Constance University of Applied Sciences will focus to an even greater extent on special research priorities and interdisciplinarity. For this reason three new institutes have been set up.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/university-strengthens-applied-research
  • Article - 12/02/2008

    Hermann Bujard - a passionate basic researcher

    As one of the people who initiated the establishment of EMBL and in his role as founding director of the ZMBH Hermann Bujard has made a considerable contribution to the transformation of Heidelberg into a leading location for molecular and biological research in Germany. As the director of EMBO Bujard is now promoting the development of molecular biosciences across Europe.

    https://www.gesundheitsindustrie-bw.de/en/article/news/hermann-bujard-a-passionate-basic-researcher
  • Article - 11/02/2008

    One-Stop-Service for SMEs

    European Commission Vice President Günter Verheugen launched Enterprise Europe Network a new and powerful European support network for enterprises. All major players of the business support community in Europe have united to offer a one-stop service to assist especially small and medium sized enterprises.

    https://www.gesundheitsindustrie-bw.de/en/article/news/one-stop-service-for-smes
  • Article - 11/02/2008

    Human clones and reprogrammed skin cell

    In 1998 James Thomson was the first to generate stem cells from human embryos. BIOPRO will present the new methods in the field of embryonic stem cell research. Stem cell experts regeneration biologists medics and ethicists will explain whether they think that the new methods are useful or not.

    https://www.gesundheitsindustrie-bw.de/en/article/news/human-clones-and-reprogrammed-skin-cell
  • Article - 11/02/2008

    Reinhart Koselleck Projects

    A new funding module from the German Research Foundation provides funding to the tune of up to 1.25 million euros.

    https://www.gesundheitsindustrie-bw.de/en/article/news/reinhart-koselleck-projects
  • Press release - 11/02/2008

    BPI opens office in Brussels

    The new BPI office in Brussels will represent the European interests of German location-oriented pharmaceutical companies at European institutions. It is headed by Dr. Alexander Natz a lawyer who previously worked for the Sträter law firm in Bonn.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/bpi-opens-office-in-brussels
  • Press release - 11/02/2008

    Priority programme "Membrane envelope of virus particles and cellular structures"

    Applications written in English must be submitted to DFG by 31st March 2008.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/priority-programme-membrane-envelope-of-virus-particles-and-cellular-structures
  • Article - 10/02/2008

    The only professorship for preclinical imaging in Europe is in Tübingen

    The University of Tübingen opened its new laboratory for Preclinical Imaging and Imaging Technology of the Werner Siemens Foundation. The professorship is the only one in Europe combining preclinical imaging and the development of new imaging technologies.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-only-professorship-for-preclinical-imaging-in-europe-is-in-tuebingen
  • Press release - 10/02/2008

    Nycomed’s Ciclesonide to be commercialised in the United States by Sepracor

    Nycomed has granted Sepracor Inc. NASDAQ SEPR the exclusive development marketing and commercialisation rights for Ciclesonide in the United States. Ciclesonide is Nycomeds patented corticosteroid with a novel principle of action.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nycomed-s-ciclesonide-to-be-commercialised-in-the-united-states-by-sepracor
  • Article - 10/02/2008 DAccepted the invitation to come to Reutlingen and talk about biomarkers (from left to right) - Mike Spain, Hanno Langen, Thomas Caskey, Larry Gold, Oliver Poetz, Thomas Joos und Hans Berger (Photo: NMI)

    4th Biomarker Workshop at the NMI in Reutlingen: another success

    The Biomarker Workshop held at the NMI in late January has become a fixed date for a growing number of proteomics researchers. With an attendance of 130 this years workshop exceeded all previous ones. Those who were keen to find out more about the latest trends and findings were presented with a successful mix of basic and applied research information.

    https://www.gesundheitsindustrie-bw.de/en/article/news/4th-biomarker-workshop-at-the-nmi-in-reutlingen-another-success

Page 116 / 119

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search